Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors

Modern Pathology

Volumn 26, Issue 5, 2013, Pages 685-696

  Li, Su Chen ^a   Essaghir, Ahmed ^b   Martijn, Cécile ^a   Lloyd, Ricardo V ^c   Demoulin, Jean Baptiste ^b   Öberg, Kjell ^a,d   Giandomenico, Valeria ^a,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b DE DUVE INSTITUTE   (Belgium)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

laser microdissection; microRNA profile; neuroendocrine tumor specimens

Indexed keywords

MICRORNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MALE; NEUROENDOCRINE TUMOR; NORTHERN BLOTTING; PRIORITY JOURNAL; RARE DISEASE; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SMALL INTESTINE CANCER; WELL DIFFERENTIATED SMALL INTESTINAL NEUROENDOCRINE TUMOR;

EID: 84877051451     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.216     Document Type: Article

References (39)

1. Bosman TF, Carneiro F, Hruban RH, et al. (eds). WHO Classification of Tumours of the Digestive System. IARC Press: Lyon; 2010; p 13.
2. Rindi G, Falconi M, Klersy C, et al. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst 2012;104:764-777.
3. Essand M, Leja J, Giandomenico V, et al. Oncolytic viruses for the treatment of neuroendocrine tumors. Horm Metab Res 2011;43:877-883.
4. Rindi G, Wiedenmann B. Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol 2012;8:54-64.
5. Cunningham JL, Diaz de Stahl T, Sjoblom T, et al. Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors. Genes Chromosomes Cancer 2011;50: 82-94.
6. Cunningham JL, Janson ET. The biological hallmarks of ileal carcinoids. Eur J Clin Invest 2011;41:1353-1360.
7. Essand M, Vikman S, Grawe J, et al. Identification and characterization of a novel splicing variant of vesicular monoamine transporter 1. J Mol Endocrinol 2005;35: 489-501.
8. Leja J, Dzojic H, Gustafson E, et al. A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy. Clin Cancer Res 2007;13: 2455-2462.
9. Leja J, Yu D, Nilsson B, et al. Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells. Gene Therapy 2011;18:1052-1062.
10. Vikman S, Giandomenico V, Sommaggio R, et al. CD8\+ T cells against multiple tumor-associated antigens in peripheral blood of midgut carcinoid patients. Cancer Immunol Immunother 2008;57:399-409.
11. Cui T, Hurtig M, Elgue G, et al. Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors. PLoS One 2010;5:e16010.
12. Leja J, Essaghir A, Essand M, et al. Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas. Mod Pathol 2009;22:261-272.
13. Garzon R, Marcucci G, Croce CM. Targeting micro-RNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010;9:775-789.
14. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
15. Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004;5:396-400.
16. Sakamoto S, Aoki K, Higuchi T, et al. The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway. Mol Cell Biol 2009;29:3754-3769.
17. Zhong X, Coukos G, Zhang L. miRNAs in human cancer. Methods Mol Biol 2012;822:295-306.
18. Brown BD, Naldini L. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat Rev Genet 2009;10:578-585.
19. Lee HW, Lee EH, Ha SY, et al. Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors. Pathol Int 2012;62:583-591.
20. Markou A, Liang Y, Lianidou E. Prognostic, therapeutic and diagnostic potential of microRNAs in nonsmall cell lung cancer. Clin Chem Lab Med 2011; 49:1591-1603.
21. Voortman J, Lee JH, Killian JK, et al. Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors. Proc Natl Acad Sci USA 2010;107:13040-13045.
22. Ruebel K, Leontovich AA, Stilling GA, et al. MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression. Mod Pathol 2010;23:367-375.
23. Gao Y, Schug J, McKenna LB, et al. Tissue-specific regulation of mouse microRNA genes in endodermderived tissues. Nucleic Acids Res 2011;39:454-463.
24. Saeed AI, Bhagabati NK, Braisted JC, et al. TM4 microarray software suite. Methods Enzymol 2006;411:134-193.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25: 402-408.
26. Nakamura N, Ruebel K, Jin L, et al. Laser capture microdissection for analysis of single cells. Methods Mol Med 2007;132:11-18.
27. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120: 15-20.
28. Allegra A, Alonci A, Campo S, et al. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (Review). Int J Oncol 2012;;41: 1897-1912.
29. You JS, Jones PA. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 2012;22:9-20.
30. Braun T, Voland P, Kunz L, et al. Enterochromaffin cells of the human gut: sensors for spices and odorants. Gastroenterology 2007;132:1890-1901.
31. Leu FP, Nandi M. GPCR somatostatin receptor extracellular loop 2 is a key ectodomain for making subtype-selective antibodies with agonist-like activities in the pancreatic neuroendocrine tumor BON cell line. Pancreas 2010;39:1155-1166.
32. Millar RP, Newton CL. The year in G protein-coupled receptor research. Mol Endocrinol 2010;24:261-274.
33. Woehler A, Ponimaskin EG. G protein-mediated signaling: same receptor, multiple effectors. Curr Mol Pharmacol 2009;2:237-248.
34. Kaku M, Nishiyama T, Yagawa K, et al. Establishment of a carcinoembryonic antigen-producing cell line from human pancreatic carcinoma. Gann 1980;71:596-601.
35. Cui T, Tsolakis AV, Cunningham J, et al. Olfactory receptor 51E1 is a potential novel tissue biomarker for the diagnosis and prognosis of small intestine neuroendocrine tumors. Regul Pept 2012;177:S18.
36. Hamfjord J, Stangeland AM, Hughes T, et al. Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing. PLoS One 2012;7:e34150.
37. Heneghan HM, Miller N, Kerin MJ. MiRNAs as biomarkers and therapeutic targets in cancer. Curr Opin Pharmacol 2010;10:543-550.
38. Roldo C, Missiaglia E, Hagan JP, et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006;24:4677-4684.
39. Cortez MA, Bueso-Ramos C, Ferdin J, et al. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011;8:467-477.